Skip to main content
. 2017 Apr 3;18(3):543–550. doi: 10.3348/kjr.2017.18.3.543

Table 1. Patient Characteristics.

GD (n = 36)
Age (years) 45.3 ± 13.8
Sex (M:F) 10:26
Previous treatment history due to GD (yes:no) 10:26
T3 (ng/dL) 262.8 ± 118.8
Free T4 (ng/dL) 3.22 ± 2.72
T3/free T4 ratio 91.4 ± 24.4
TSH (µIU/mL) 0.05 ± 0.01
TSHR-Ab (IU/L) 17.7 ± 24.8
Initial MMI dose (mg/day) 19.4 ± 8.4

T3 (79–200 ng/dL), free T4 (0.89–1.79 ng/dL), TSH (0.3–4.0 µIU/mL), and TSHR-Ab (0–1.0 IU/L). GD = Graves' disease, MMI = methimazole, TSH = thyroid-stimulating hormone, TSHR-Ab = thyroid-stimulating hormone receptor antibody